-
Medical insurance ushered in a heavy policy, and the era of strictest supervision is coming!
Time of Update: 2021-09-11
02Equipped with professional auditors In terms of audit staff, Article 6 of the Interim Measures states that handling agencies should strengthen the construction of medical security auditing capabilities, allocate staff, and hire relevant agencies and professionals to assist in inspections according to work needs; qualified provincial, municipal, and county medical services The security department may set up an independent medical security audit institution to undertake the medical security audit work .
-
National Health Commission: The introduction of restrictive measures violates the principle of vaccination
Time of Update: 2021-09-11
Wu Liangyou stated that the new crown virus vaccination should be carried out in accordance with the principles of informed, consent, voluntariness and seeking truth from facts, and emphasized that when introducing vaccination policies and measures, we must be rigorous and carefully evaluated to ensure compliance with laws and regulations and strictly adhere to the bottom line of safety .
-
HER2 ADC innovation wave!
Time of Update: 2021-09-11
In January 2020, T-DM1 was approved for marketing by NMPA, and its indication is adjuvant for patients with HER2-positive early breast cancer who still have aggressive lesions after receiving neoadjuvant therapy based on taxanes combined with trastuzumab Treatment .
-
Innovent's GLP-1R/GCGR dual agonist in the treatment of diabetes phase II clinical completed the first case of administration
Time of Update: 2021-09-11
On September 8, Cinda Biopharmaceuticals announced its glucagon-like peptide-1 receptor (GLP-1R)/glucagon receptor (GCGR) dual agonist The Phase II clinical study of IBI362 in diabetic subjects completed the first subject administration .
The main purpose is life> .
-
"Science": New crown virus traceability should pay attention to the possibility of cold chain transmission
Time of Update: 2021-09-11
The article said that the African swine fever epidemic in 2019 caused a shortage of pork products in China.
Large-scale demand has promoted the cold chain supply of all meat varieties, which may transport SARS-like coronavirus-susceptible animals .
-
Many governments and scholars voice their opposition to the politicization of the source of the new crown
Time of Update: 2021-09-11
On September 8, local time, the Ministry of Foreign Affairs of Sri Lanka issued the "Statement on the Traceability of the New Coronavirus", opposing the politicization of the traceability of the virus and demanding respect for the authority of the World Health Organization's joint research reports .
-
Oxbryta Sickle Cell Disease Pediatric Indications & Dispersible Tablets Received Priority Review by the U.S. FDA
Time of Update: 2021-09-11
At the European Hematology Association (EHA) 2021 online meeting, a data analysis of 45 SCD children aged 4 to 11 years old showed that Oxbryta dispersible tablets (the subject of NDA) were used for weight-based treatment After that, hemoglobin continued to improve rapidly, and hemolysis (or red blood cell destruction) was also reduced .
-
New chemical structure!
Time of Update: 2021-09-11
Text|Pharmaceutical Mission HillsOn September 8, Kangchen Pharmaceutical issued an announcement stating that its Class 1 new drug KC1036 was in line with the expected research results in the phase 1 clinical study for the treatment of patients with advanced solid tumors.
-
Small interference nucleic acid therapy opens a new path for long-term lipid-lowering
Time of Update: 2021-09-11
"Professor Huo Yong from Peking University First Hospital said: Experts at the meeting believed that although the current statin therapy is effective in reducing LDL-C, the Chinese population using high-dose statins is more likely to have the risk of drug-induced myopathy and increased liver enzymes than other ethnic groups, so most Chinese people can only receive medium-dose statin treatment, and poor treatment compliance has further led to a low rate of compliance with statin treatment in patients .
-
Gan Lai Pharmaceutical's THRβ agonist phase I clinical trial in the United States achieved good top-line data
Time of Update: 2021-09-11
On September 8th, Gan Lai Pharmaceutical, a wholly-owned subsidiary of Gerry Pharmaceuticals, announced that the liver-targeted prodrug ASC41 oral tablet healthy subjects drug interactions and the pharmacokinetics of non-alcoholic fatty liver disease (NAFLD) patients PK (Phase I clinical trials in the United States) achieved good top-line data .
-
Horizon Therapeutics' thyroid eye disease drug Tepezza enters Phase 4 clinical trials
Time of Update: 2021-09-11
Horizon Therapeutics recently announced that a Phase 4 clinical trial (NCT04583735) evaluating the efficacy and safety of Tepezza (teprotumumab) in the treatment of chronic (inactive) thyroid eye disease (TED) has enrolled the first patient .
-
Delta strain infections have been reported in 174 countries and regions
Time of Update: 2021-09-11
47 million new confirmed cases of new coronary pneumonia worldwide, except for the number of new cases in the Americas.
Increased, and the number of new cases in other regions decreased .
-
The first generic carfilzomib for injection of Hausen Pharmaceuticals was approved for only two months after the original research report
Time of Update: 2021-09-11
From: CDE official websiteCarfilzomib (carfilzomib) is a proteasome inhibitor, approved by the FDA on July 20, 2012, for patients with multiple myeloma who have received at least two previous types (bortezomib and immunomodulators).
-
Wu Ziliang: Walking slowly and steady is science
Time of Update: 2021-09-11
Wu Ziliang: Walking slowly and steady is science Wu Ziliang: Walking slowly and steady is the science Wu Ziliang: Walking slowly and steady is the science Intern reporter Sun Min
-
Youhe Medicine's CD40 in the treatment of advanced solid tumors in China completed the first patient medication in the Phase I clinical study
Time of Update: 2021-09-11
This clinical study aims to evaluate the safety, tolerability and pharmacokinetics of YH003 in subjects with advanced solid tumors .
This study is a multi-center, open-ended, phase I dose escalation study evaluating the safety, tolerability and pharmacokinetics of YH003 in patients with advanced solid tumors .
-
The heavy rain caused the production of Atractylodes macrocephala to decrease, and the contradiction between supply and demand has not been reversed!
Time of Update: 2021-09-11
The price of the disaster-affected in the early period has risen Anguo Market: Affected by the rainfall in the Anhui production area, the number of Atractylodes macrocephala seeking goods in the market increased, and prices continued to rise .
-
National Health Commission: 28 new confirmed cases, all imported from abroad
Time of Update: 2021-09-11
As of 24:00 on September 8, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 786 confirmed cases (including 8 severe cases), a total of 89,689 cured and discharged cases, and a total of 4,636 deaths.
-
Cinda Biotech declares that the first domestic SIRPα antibody CD47 pathway has deployed 3 new drugs
Time of Update: 2021-09-11
Author: Plus OneOn September 8, Cinda Biotech declared a new type of anti-SIRP-alpha antibody IBI397 (Alector R&D code: AL008) .
Domestic CD47 antibody drug development pattern (Insight)Cinda has already deployed 3 products for CD47-SIRPα, including CD47 monoclonal antibody IBI188 (letaplimab) and PD-L1/CD47 double antibody IBI322.
-
The industry analyzes the sustainable development capacity building of the enterprise from the research and development expense investment of the pharmaceutical company
Time of Update: 2021-09-11
In addition, in recent years, Zhongsheng Pharmaceutical’s R&D investment has continued to increase, and 50% of the projects entering the clinical stage are independent research and development products .
-
Knowing about the stability of pharmaceutical packaging materials
Time of Update: 2021-09-11
Research on the stability of pharmaceutical packaging materials is generally carried out by pharmaceutical packaging material manufacturers to confirm the quality stability period of their products under specified storage conditions.
